| [O2–14–01]: Aβ OLIGOMER ELIMINATING D‐ENANTIOMERIC PEPTIDES ENHANCE COGNITION AND IMPEDE NEURODEGENERATION EVEN BY ORAL APPLICATION D Willbold Alzheimer's & Dementia 13 (7S_Part_11), P591-P591, 2017 | | 2017 |
| [P2–053]: CYCLIC D‐ENANTIOMERIC PEPTIDE TARGETING AMYLOID‐BETA IN ALZHEIMER's DISEASE AE Schartmann, S Schemmert, LHE Leithold, N Jiang, T Ziehm, ... Alzheimer's & Dementia 13 (7S_Part_12), P624-P625, 2017 | | 2017 |
| [P3–034]: TREATMENT WITH AN ALL D‐ENANTIOMERIC PEPTIDE IMPROVES COGNITIVE AND MOTORIC IMPAIRMENT IN TWO DIFFERENT ALZHEIMER MOUSE MODELS S Schemmert, AE Schartmann, J Kutzsche, A Willuweit, D Willbold Alzheimer's & Dementia 13 (7S_Part_19), P942-P943, 2017 | 1 | 2017 |
| [P4–385]: SFIDA: PLATFORM TECHNOLOGY FOR DIAGNOSTICS OF PROTEIN MISFOLDING DISEASES O Bannach, C Zafiu, A Kulawik, Y Herrmann, M Pils, T Bujnicki, D Willbold Alzheimer's & Dementia 13 (7S_Part_30), P1440-P1440, 2017 | | 2017 |
| [P4–580]: SURPRISINGLY HIGH RESISTANCE OF Aβ OLIGOMER ELIMINATING ALL‐D‐ENANTIOMERIC PEPTIDES AGAINST METABOLIZATION BY ENZYMES CONTAINED IN THE GASTROINTESTINAL TRACT, BLOOD … A Elfgen, B Santiago‐Schübel, S Sacchi, L Pollegioni, J Kutzsche, ... Alzheimer's & Dementia 13 (7S_Part_32), P1575-P1575, 2017 | | 2017 |
| 05y. Drug Development & Clinical Trials: other ADPD5-1992 D-PEPTIDES DEVELOPED TO BE THERAPEUTICALLY ACTIVE AGAINST BETA-AMYLOID OLIGOMERS SHOW PROMISING PHARMACOKINETIC PROPERTIES LHE Leithold, N Jiang, J Post, J Kutzsche, D Jürgens, KJ Langen, ... Neurodegener Dis 15, 1, 2015 | | 2015 |
| 1H, 13C, and 15N backbone and sidechain resonance assignments of a monomeric variant of E. coli deoxyribose-5-phosphate aldolase M Schulte, M Stoldt, P Neudecker, J Pietruszka, D Willbold, V Panwalkar Biomolecular NMR assignments 11, 197-201, 2017 | 2 | 2017 |
| 1H, 13C, and 15N resonance assignment of a 179 residue fragment of hepatitis C virus non-structural protein 5A S Feuerstein, Z Solyom, A Aladağ, S Hoffmann, D Willbold, B Brutscher Biomolecular NMR assignments 5, 241-243, 2011 | 12 | 2011 |
| 1H, 15N and 13C resonance assignment of the N-terminal C39 peptidase-like domain of the ABC transporter Haemolysin B (HlyB) J Lecher, M Stoldt, CKW Schwarz, SHJ Smits, L Schmitt, D Willbold Biomolecular NMR assignments 5, 199-201, 2011 | 5 | 2011 |
| 13. Desynchronisation of neuronal network activity in traumatic brain injury F Otto, J Opatz, R Hartmann, D Willbold, E Donauer, M Siebler Clinical Neurophysiology 1 (120), e11, 2009 | | 2009 |
| 2.4 Experimental evidence for an Aβ pentamer/hexamer in solution M Wolff, B Zhang-Haagen, C Decker, B Barz, M Schneider, R Biehl, ... Investigation of amyloid beta peptide aggregation by small angle neutron …, 0 | | |
| 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets D WILLBOLD Pharm Res 33 (2), 328-336, 2016 | | 2016 |
| 3.3 Relevance of C-terminal residues for amyloid-β binding to platelet integrin αIIbβ3 and amyloid-β fibril formation L Donner, L Gremer, T Ziehm, CGW Gertzen, H Gohlke, D Willbold, ... Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung, 23, 0 | | |
| 3.4 sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body liquids Y Herrmann, A Kulawik, K Kühbach, M Hülsemann, L Peters, T Bujnicki, ... Automatisierung und Kalibrierung des sFIDA-Assays zur frühzeitigen Diagnose …, 0 | | |
| 3.5 Nanoparticle standards for immuno-based quan-titation of α-synuclein oligomers in diagnostics of Parkinson’s disease and other synucleopathies Y Herrmann, T Bujnicki, C Zafiu, L Peters, A Kulawik, K Kühbach, J Fabig, ... Automatisierung und Kalibrierung des sFIDA-Assays zur frühzeitigen Diagnose …, 2017 | | 2017 |
| 68. Mosbacher Kolloquium W Hoyer, EA Mirecka, H Shaykhalishahi, CS Grüning, A Gauhar, ... | | |
| 767 C-SRC IS REQUIRED FOR VIRAL REPLICATION AS IT MEDIATES COMPLEX FORMATION BETWEEN THE HEPATITIS C VIRUS ENCODED PROTEINS NS5A AND NS5B A Pfannkuche, B Katrin, J Karthe, M Poenisch, R Bartenschlager, ... Journal of Hepatology, S309, 2011 | | 2011 |
| A beta oligomer eliminating D-enantiomeric peptides enhance cognition and impede neurodegeneration in transgenic Alzheimer's disease mouse models even by oral application D Willbold NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 391, S17-S17, 2018 | | 2018 |
| A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity K Koch, R Hartmann, J Tsiampali, C Uhlmann, AC Nickel, X He, MA Kamp, ... Cell death discovery 6 (1), 20, 2020 | 68 | 2020 |
| A computer-aided approach for the discovery of D-peptides as inhibitors of SARS-CoV-2 main protease JE Hernández González, RJ Eberle, D Willbold, MA Coronado Frontiers in molecular biosciences 8, 816166, 2022 | 11 | 2022 |
Wolfgang HoyerInstitute of Physical Biology, Heinrich Heine University Duesseldorf在 uni-duesseldorf.de 的电子邮件经过验证
